The article "Intravenous Colchicine in the Management of Gouty Arthritis" by W. Graham and J. B. Roberts, which appeared in your issue of March, 1953 (1) It is quite obvious that much research has gravitated recently to studying the structure and biochemistry of connective tissue. These problems are extremely complicated and various papers were given to try to elucidate the factors governing the growth and pathology of collagen, elastic tissue, etc. This work, in its initial stages, is mostly grounded in theory but may well bear considerable fruit in the near future.
With regard to the hormones, P. S. Hench stresses the importance of assessing each patient individually. Of his "systems" the one of small doses over long periods seems to be preferred; he still uses gold in suitable cases. E. G. L. Bywaters and others have found little difference in the results of treating rheumatic fever with ACTH, cortisone, or salicylate. Most authors agree that small intra-articular doses of hormone are decidedly beneficial, especially in the knee-joint. Hormones are thought to be of little value in degenerative arthritis.
The reports on Butazolidin were very favourable. Some consider that the remissions last longer than those with ACTH. The numerous complications should not preclude its use. It is effective in gout but especially so in rheumatoid arthritis and ankylosing spondylitis. Modern opinion is that it does not act by stimulating the pituitaryadrenal mechanism.
Plastic operations on the hip-joint seem to produce good results in 60-80 per cent. of cases; R. J. Judet considers severe pain one of the main indications for operation, but believes in persevering with conservative measures prior to surgery.
The papers on rehabilitation were along the usual lines.
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